Alibaba, Xiaomi, Kyushutong, Kang Enbei, Baiyang Medicine, these leading companies in the industry, now have a common interest intersection - Internet medical . This borderless cross-industry hotspot is becoming a topic of increasing capital attention.
In the first ten days of December 2014, mobile phone manufacturer Xiaomi cross-border investment in wearable health equipment, pharmaceutical company Kang Enbei through mergers and acquisitions into the drug e-commerce, health asset management group Baiyang Pharmaceutical announced the creation of a comprehensive online medical The solution, a lot of big incidents came one after another, "medical on the fingertips" ushered in hot heat.
After the mobile industry in the consumer goods industry, the mobile information technology is subverting the most special attributes of medicines and medical services. In the three major areas of drug sales, hardware manufacturing and medical services, Internetization is taking place.
Recently, Paigang, chairman of Baiyang Pharmaceutical Group, said in an exclusive interview with the 21st Century Business Herald that the rules of the Internet are integration, optimization and cooperation. The volume of funds is not the most important indicator of Internet medical care. “Building this industry is a time-consuming process. Internet companies and medical companies are faced with different thresholds and they have to be broken.â€
In the camp of Internet companies and traditional pharmaceutical companies and medical providers, on the one hand, there are constantly “new players†entering and new products being launched. On the other hand, there are still not enough successful profit models and a wide range of solutions. For reference, the uncertainty here has also become a great resistance for the investment community and industry to promote Internet medical care.
Pharmaceutical retail: the policy door will open
As the year is approaching, it is regarded as one of the most important events in the industry in 2014, and the new drug market will eventually land. This landmark event also means that China's drug sales policy is showing an unprecedented trend of relaxation.
According to various sources, the new regulations for online drug sales, "Internet Food and Drug Administration Supervision and Management Measures" are likely to be fully implemented on January 1, 2015, which will not only enable OTC (over-the-counter drugs) that have already been sold in e-commerce channels. Further formalization with health care products, online sales of prescription drugs that have been strictly controlled before will also be lifted.
Policy has come to the fore, and more and more large listed companies are eager to try new water channel sales.
Following Jiuzhoutong, Shanghai Pharmaceutical, Kangmei Pharmaceutical and other pharmaceutical companies, Kang Enbei, a domestic botanical drug company, also joined the e-commerce army at the beginning of this month, and acquired a 30.81% stake in the pharmaceutical B2B e-commerce Zhencheng Pharmaceutical through the consideration of 271 million yuan. In one fell swoop, it has the "medical online" sales platform created by the latter and the informationized pharmaceutical logistics distribution system covering many medical institutions.
Not only is the sales side boiling because of the New Deal, but even the pharmaceutical marketing line has spread from offline to the Internet. Baiyang Medicine is one of the earliest "people who eat crabs."
As one of the first online pharmacies in China, Baiyang Medicine has a dedicated team of about 100 people specializing in medical information applications. According to its chairman, Fu Gang, there are only a handful of companies in the industry that invest hundreds of millions of dollars in online R&D every year. The reason for the radicalization is because the group believes that "the change of information technology to the industry will enable them to find a chance to overtake a corner in a manufacturing field."
At present, Baiyang Pharmaceutical has two major layouts for pharmaceutical e-commerce: one is to do precise marketing on the Internet to improve the communication efficiency of the brand. This practice has become a common practice in the field of fast-moving, but there are few drugs in the field of advertising marketing. Some people try; the second is to develop the drug O2O system, and strive to create an integrated distribution model of “doctors prescribe drugs online, patients take drugs offlineâ€.
In the past five years, with the transformation and precipitation of the electricity business, domestic pharmaceutical e-commerce channels are also exploring a variety of platform architectures and profit models. Representative enterprises mainly include third-party platforms such as Tmall Medicine and Jingdong Medical City, self-built platforms such as Jiuzhoutong and Yixintang, and vertical pharmaceutical e-commerce such as Jianyi.
JIANGSU CLS TECHNOLOGY CORP.LTD , https://www.js-cls.com